Targeting Interstitial Myofibroblast-Expressed Integrin αvβ3 Alleviates Renal Fibrosis-Reference-Cited by-同舟云学术

Targeting Interstitial Myofibroblast-Expressed Integrin αvβ3 Alleviates Renal Fibrosis

Published:2021-02-05 Issue:3 Volume:18 Page:1373-1385
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zhou Jian¹²,Li Rui¹²,Zhang Jinhang¹²,Liu Qinhui¹,Wu Tong¹²,Tang Qin¹²,Huang Cuiyuan¹²,Zhang Zijing¹²,Huang Ya¹²,Huang Hui¹²,Zhang Guorong¹²,Zhao Yingnan¹²,Zhang Ting²,Mo Li³,Li Yanping¹,He Jinhan¹²^ORCID

Affiliation:

1. Laboratory of Clinical Pharmacy and Adverse Drug Reaction, West China Hospital of Sichuan University, Chengdu 610041, China

2. Department of Pharmacy, West China Hospital of Sichuan University, Chengdu 610041, China

3. Center of Gerontology and Geriatrics, West China Hospital of Sichuan University, Chengdu 610041, China

Funder

National Natural Science Foundation of China

West China Hospital of Sichuan University

Sichuan Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c01182

Reference49 articles.

1. Temporary warm ischaemia, 5/6 nephrectomy and single uranylnitrate administration — comparison of three models intended to cause renal fibrosis in rats

2. Progression and potential regression of glomerulosclerosis

3. Up‐regulation of endoglin, a TGF‐β‐binding protein, in rats with experimental renal fibrosis induced by renal mass reduction

4. Mechanisms of Renal Fibrosis

5. Cellular and molecular mechanisms of renal fibrosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways;International Immunopharmacology;2024-08

2. Brain-Derived Neurotrophic Factor-Loaded Low-Temperature-Sensitive liposomes as a drug delivery system for repairing podocyte damage;International Journal of Pharmaceutics;2024-07

3. A quantitative review of nanotechnology‐based therapeutics for kidney diseases;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Nanoparticles as Drug Delivery Systems: Advances and Challenges;Nanotechnology;2024

5. Cucurbit[7]uril‐Mediated Organ‐Specific Delivery of Ultrasmall NIR‐II Luminescent Gold Nanocarriers for Therapy of Acute Kidney Injury;Advanced Functional Materials;2023-10-17